Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

Abilify

The Top Pharma List's top 50 pharmaceutical products by global sales ranking is compiled from GlobalData's pharmaceutical revenue figures. Abilify was produced by Otsuka and Bristol-Myers Squibb.

Amgen biosimilar matches AbbVie's Humira in psoriasis trial

Amgen biosimilar matches AbbVie's Humira in psoriasis trial Enbrel. Amgen/Pfizer. 8, 897. Seretide/Advair. GSK. 8, 356. Abilify. BMS/Otsuka. 8, 031.

Lundbeck launches Brintellix in first EU market

Lundbeck launches Brintellix in first EU market Since then, the company has launched not only Brintellix but also a long-acting version of schizophrenia drug Abilify (aripiprazole) and alcohol addiction treatment Selincro (nalmefene) that have allowed it to

This month in 1989: the creation of Bristol-Myers Squibb

This month in 1989: the creation of Bristol-Myers Squibb It's a strategy that paid off and BMS has continued to be one of the leading global pharma companies, launching products such as antidepressant Abilify (aripiprazole) and diabetes standard Glucophage

Otsuka and Lundbeck file Abilify follow-up in the US

Otsuka and Lundbeck file Abilify follow-up in the US Otsuka and Lundbeck have filed for approval of brexpiprazole - their follow-up to blockbuster antipsychotic Abilify - in the US. ... year. A long-acting follow-up called Abilify Maintena reached the market last year, which helped defend the franchise

Lundbeck's desmoteplase flunks phase III stroke trial

Lundbeck's desmoteplase flunks phase III stroke trial vortioxetine), once-monthly schizophrenia drug Abilify Maintena (aripiprazole) and alcohol dependence therapy Selincro (nalmefene).

[ Previous 5 results ] 2 3 4 5 6 7 8 9 10 11 [ Next 5 results ]

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
mXm Medical Communications

mXm Medical Communications meets the needs of pharmaceutical marketers and medics who require a highly experienced, bespoke service from their...

Latest intelligence

Report: Customer experience, shaping digital healthcare
In this issue of ‘Perspective’ we speak with industry experts to learn about the world of digital healthcare, and how pharma is beginning to utilise these modern technologies to enhance...
Biomarker
Encouraging signs in biomarker R&D
The cancer immunotherapy firms ramping-up biomarker R&D...
Programmatic methodology and why you should be using it
What is it? How does it work? Why is everyone talking about it? By Richard Webb - Associate Director...

Infographics